U.S. Markets open in 8 hrs 53 mins

Novartis’s Stock Performance following the AveXis Agreement

Mike Benson
Novartis’s Stock Performance following the AveXis Agreement

Novartis AG (NVS) announced an agreement and plan for a merger with AveXis on April 9, 2018. Following the recovery of major US indexes after the US-China trade war concerns—and also due to the announcement of the acquisition—Novartis AG’s ADR (American depositary receipt) reported a 1.1% rise in its price to close at $81.07 on April 9 compared to its previous close of $80.20 on April 6.